Novartis buys priority review voucher from Pharming for discount price of $21M

Novartis buys priority review voucher from Pharming for discount price of $21M

Source: 
Fierce Biotech
snippet: 

Novartis has acquired a priority review voucher from Pharming for the bargain price of $21.1 million, thanks to some shrewd dealmaking dating back a few years.